Securities code: 002020 securities abbreviation: Zhejiang Jingxin Pharmaceutical Co.Ltd(002020) Announcement No.: 2021070 Zhejiang Jingxin Pharmaceutical Co.Ltd(002020)
Announcement on resolutions of the 28th meeting of the 7th board of directors
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Zhejiang Jingxin Pharmaceutical Co.Ltd(002020) the notice of the 28th meeting of the seventh board of directors was sent by e-mail on December 8, 2021, and the meeting was held by telephone and fax on December 14, 2021. There are 9 directors who should vote at the meeting and 9 directors who actually vote. The convening of the meeting shall comply with the provisions of the company law and the articles of association. The meeting voted to form the following resolutions:
1、 The proposal on the acquisition of 100% equity and related party transactions of Guangdong Shaxi Pharmaceutical Co., Ltd. was deliberated and adopted with 8 affirmative votes, 0 negative votes and 0 abstention. The proposal still needs to be submitted to the general meeting of shareholders of the company for deliberation. Mr. LV Gang, a related director, withdrew from voting during the deliberation. For details, please refer to the company’s in the securities times, China Securities Journal and cninfo http://www.cn.info.com..cn. Announcement No. 2021072 published in.
2、 With 9 affirmative votes, 0 negative votes and 0 abstention votes, the proposal on convening the second extraordinary general meeting of shareholders in 2021 was deliberated and adopted. The company is scheduled to convene the second extraordinary general meeting of shareholders in 2021 on December 30, 2021. For details, please refer to the company’s in the securities times, China Securities Journal and cninfo http://www.cn.info.com..cn. Announcement No. 2021073 published in.
It is hereby announced.
Zhejiang Jingxin Pharmaceutical Co.Ltd(002020) board of directors December 15, 2021
